Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;25:1178-1184

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abassi, Z. A.
Right arrow Articles by Keiser, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abassi, Z. A.
Right arrow Articles by Keiser, H. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ALANINE
Medline Plus Health Information
*Heart Failure

(Hypertension. 1995;25:1178-1184.)
© 1995 American Heart Association, Inc.


Articles

Pulmonary and Renal Neutral Endopeptidase EC 3.4.24.11 in Rats With Experimental Heart Failure

Zaid A. Abassi; Shaban Kotob; Eliahu Golomb; Federico Pieruzzi; Harry R. Keiser

From the Hypertension-Endocrine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (Z.A.A., E.G., H.R.K.); Department of Microbiology, University of Maryland (S.K.), College Park, Md; and Centro di Fisiologia Clinica e Ipertensione, Ospedale Maggiore, Università di Milano (Italy) (F.P.).

Correspondence to Zaid A. Abassi, PhD, Hypertension-Endocrine Branch, National Heart, Lung, and Blood Institute, Bldg 10, Room 8C103, Bethesda, MD 20892-1754.

Abstract Congestive heart failure is characterized by avid sodium retention and a blunted renal response to exogenous and endogenous atrial natriuretic peptide. Inhibition of neutral endopeptidase EC 3.4.24.11, the main enzyme that degrades natriuretic peptides, produces a natriuretic response in different models of congestive heart failure. This raises the possibility that an increase in either the expression or activity of neutral endopeptidase is responsible for these phenomena. In the present study, we examined (1) the renal effects of SQ-28,603, a neutral endopeptidase inhibitor, in rats with moderate and severe congestive heart failure induced by an aortocaval fistula compared with sham controls, and (2) neutral endopeptidase expression and activity in the lungs and kidneys of these rats. Infusion of SQ-28,603 (40 mg/kg IV) induced a significant natriuretic response in normal rats and rats with moderate congestive heart failure. This response was blunted in rats with severe congestive heart failure. Surprisingly, renal neutral endopeptidase mRNA levels, assessed by quantitative reverse transcriptase–polymerase chain reaction; protein levels, assessed by Western blotting; and activity, assessed by gelatin gels, were comparable in all groups. Pulmonary neutral endopeptidase mRNA levels decreased by 45% in rats with severe congestive heart failure but not in rats with mild congestive heart failure. In addition, pulmonary neutral endopeptidase immunoreactivity levels and activity were significantly decreased in congestive heart failure in correlation with the severity of the disorder. We conclude that an increase in neutral endopeptidase expression or activity does not occur in rats with congestive heart failure, and therefore, an upregulation of neutral endopeptidase is unlikely to account for the blunted natriuretic response to the atrial natriuretic peptide and the positive sodium balance in congestive heart failure.


Key Words: membrane metallo-endopeptidase • heart failure, congestive • kidney • lung • natriuresis




This article has been cited by other articles:


Home page
CirculationHome page
Z. A. Abassi, K. Gurbanov, S. E. Mulroney, C. Potlog, T. J. Opgenorth, A. Hoffman, A. Haramati, and J. Winaver
Impaired Nitric Oxide–Mediated Renal Vasodilation in Rats With Experimental Heart Failure : Role of Angiotensin II
Circulation, November 18, 1997; 96(10): 3655 - 3664.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. T. Rademaker, C. J. Charles, T. Kosoglou, A. A. Protter, E. A. Espiner, M. G. Nicholls, and A. M. Richards
Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure
Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2372 - H2379.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Willenbrock, M. Scheuermann, K. Hohnel, F. C. Luft, and R. Dietz
Acute and Chronic Neutral Endopeptidase Inhibition in Rats With Aortocaval Shunt
Hypertension, June 1, 1996; 27(6): 1259 - 1266.
[Abstract] [Full Text]